Mochida, Gene Techno Science Pair Up for Regenerative Medicines for Rare Gastrointestinal Diseases

March 24, 2020
Mochida Pharmaceutical and Gene Techno Science, a Hokkaido University spin-off, entered into a business partnership agreement to develop and commercialize regenerative medicines in Japan for orphan and intractable diseases in the GI field such as intestinal hypoganglionosis (IHG), they said...read more